Loading...
Loading...
Browse all stories on DeepNewz
VisitAMD Invests $20M in AI-Driven Absci Structured as PIPE to Boost Drug Discovery Efforts
Jan 8, 2025, 11:50 AM
Advanced Micro Devices (AMD) has made a $20 million investment in Absci Corporation (ABSI), a company focused on AI-driven drug discovery. This strategic investment, reported by the Wall Street Journal, is part of AMD's initiative to market its AI semiconductors to the healthcare sector. The investment is structured as a private investment in public equity (PIPE) and aims to assist Absci in reducing its hardware costs by migrating some of its workloads to AMD's technology. This move underscores AMD's commitment to expanding its presence in the healthcare industry through innovative AI applications.
View original story
Markets
No • 50%
Yes • 50%
Absci Corporation's financial reports or official press releases
No • 50%
Yes • 50%
Scientific publications or Absci's official announcements
Yes • 50%
No • 50%
AMD's official press releases or financial disclosures
Stock price increases by more than 20% • 25%
Stock price decreases • 25%
Stock price changes by less than 10% • 25%
Stock price increases by 10-20% • 25%
Absci Corporation's stock market performance data
10% to 20% • 25%
More than 30% • 25%
Less than 10% • 25%
20% to 30% • 25%
Market research reports or industry analysis publications
Not adopted • 25%
Fully adopted across all pipelines • 25%
Partially adopted in some pipelines • 25%
Minimal adoption • 25%
Absci Corporation's technology adoption reports or official announcements